Copyright
©The Author(s) 2017.
World J Cardiol. Aug 26, 2017; 9(8): 673-684
Published online Aug 26, 2017. doi: 10.4330/wjc.v9.i8.673
Published online Aug 26, 2017. doi: 10.4330/wjc.v9.i8.673
LVID; d (mm) | LVID; s (mm) | FS (%) | SV (μL) | HR (bpm) | CO (mL/min) | ||
DTG | Male | 4.49 ± 0.47 | 3.90 ± 0.60 | 13.95 ± 4.2 | 24.10 ± 2.60 | 566 ± 30 | 13.59 ± 1.33 |
Female | 4.53 ± 0.18 | 3.99 ± 0.29 | 12.02 ± 3.05 | 23.34 ± 3.11 | 621 ± 24 | 14.35 ± 1.30 |
- Citation: Bruns DR, Ghincea AR, Ghincea CV, Azuma YT, Watson PA, Autieri MV, Walker LA. Interleukin-19 is cardioprotective in dominant negative cyclic adenosine monophosphate response-element binding protein-mediated heart failure in a sex-specific manner. World J Cardiol 2017; 9(8): 673-684
- URL: https://www.wjgnet.com/1949-8462/full/v9/i8/673.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i8.673